Adamis Pharmaceuticals Corp (ADMP)-医療機器分野:企業M&A・提携分析

◆英語タイトル:Adamis Pharmaceuticals Corp (ADMP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011242
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe is developed for anaphylactic reactions such as insect stings, foods, medications and latex. Adamis also provides pipeline products such as APC-2000 for the treatment of bronchospasms; APC-1000 and APC-5000 for the treatment of asthma and chronic obstructive pulmonary disease; and APC-3000, an HFA inhaled nasal steroid product for the treatment of allergic rhinitis. The company provides its products for patients, physicians, and healthcare organizations. It has operations in Phoenix, Arizona. Adamis is headquartered in San Diego, California, the US.

Adamis Pharmaceuticals Corp (ADMP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Adamis Pharmaceuticals Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Adamis Pharmaceuticals Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Adamis Pharmaceuticals Corp, Medical Equipment, Deal Details 10
Partnerships 10
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 10
Equity Offering 11
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 11
Adamis Pharma Raises USD11 Million in Private Placement of Units 13
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 15
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 16
Adamis Pharmaceuticals Corp – Key Competitors 17
Adamis Pharmaceuticals Corp – Key Employees 18
Adamis Pharmaceuticals Corp – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Product News 20
01/14/2016: Adamis Pharmaceuticals Announces FDA Acceptance of Resubmission of Its Epinephrine Pre-Filled Syringe NDA 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Adamis Pharmaceuticals Corp, Medical Equipment, Key Facts, 2016 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Adamis Pharmaceuticals Corp, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Adamis Pharmaceuticals Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Adamis Pharmaceuticals Corp, Deals By Market, 2011 to YTD 2017 8
Adamis Pharmaceuticals Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Adamis Pharma Enters Into Licensing Agreement With 3M Company For Taper Dry Powder Inhaler Technology 10
Adamis Pharma Raises USD17.3 Million in Public Offering of Shares 11
Adamis Pharma Raises USD11 Million in Private Placement of Units 13
Adamis Pharma Raises USD5 Million in Private Placement of Preferred Stock 15
Adamis Pharma Completes Underwriters Exercise Of Over-Allotment Option Of Public Offering Of Shares For US$25.5 Million 16
Adamis Pharmaceuticals Corp, Key Competitors 17
Adamis Pharmaceuticals Corp, Key Employees 18
Adamis Pharmaceuticals Corp, Subsidiaries 19

★海外企業調査レポート[Adamis Pharmaceuticals Corp (ADMP)-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Naspers Limited:企業の戦略・SWOT・財務分析
    Naspers Limited - Strategy, SWOT and Corporate Finance Report Summary Naspers Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Saab AB:戦略・SWOT・企業財務分析
    Saab AB - Strategy, SWOT and Corporate Finance Report Summary Saab AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Micron Technology Inc:企業のM&A・事業提携・投資動向
    Micron Technology Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Micron Technology Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Credit Guarantee Insurance Corporation of Africa Ltd:企業の戦略・SWOT・財務分析
    Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report Summary Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …
  • HUGO BOSS AG:企業の戦略・SWOT・財務情報
    HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report Summary HUGO BOSS AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Echosens SA:医療機器:M&Aディール及び事業提携情報
    Summary Echosens SA (Echosens), a subsidiary of Inner Mongolia Free Han & Mongolia Pharmaceutical Co Ltd, is a medical device company that offers diagnostic products. The company designs and develops diagnosis solutions for patients with chronic liver diseases. It offers fibrometer, fibroscan, fibro …
  • Chromatin Inc:企業のM&A・事業提携・投資動向
    Chromatin Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chromatin Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Mahaweli Reach Hotels Plc
    Mahaweli Reach Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary Mahaweli Reach Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Big River Gold Ltd (CAS):企業の財務・戦略的SWOT分析
    Summary Big River Gold Ltd (Big River Gold) is formerly known as Crusader resources Ltd is a mineral exploration company. The company explores for gold, iron ore and tin deposits. Its projects portfolio includes Borborema Gold project, Posse Iron Ore project, Tarantula Tungsten project, Juruena Gold …
  • GulfMark Offshore Inc (GLF):石油・ガス:M&Aディール及び事業提携情報
    Summary GulfMark Offshore Inc (GulfMark Offshore), formerly New GulfMark Offshore Inc is an oil and gas company that offers oil and gas, and marine transportation services. The company owns, operates, and manages fleet of vessels offering marine specialty services to offshore oil and natural gas dri …
  • Jubilee Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary Jubilee Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Mitsui E&S Holdings Co., Ltd. (7003):企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Suburban Propane Partners LP (SPH):企業の財務・戦略的SWOT分析
    Summary Suburban Propane Partners LP (Suburban Propane) distributes and markets energy-related products. The company supplies propane, fuel oil and refined fuels, and markets natural gas and electricity in deregulated markets. It also provides installation and service of various types of whole-house …
  • Drummond Company Inc:企業の戦略・SWOT・財務情報
    Drummond Company Inc - Strategy, SWOT and Corporate Finance Report Summary Drummond Company Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Altavia SA:企業の戦略的SWOT分析
    Altavia SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Strukton Groep Nv
    Strukton Groep Nv - Strategy, SWOT and Corporate Finance Report Summary Strukton Groep Nv - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • University of Oxford:企業のM&A・事業提携・投資動向
    University of Oxford - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's University of Oxford Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • AGL Energy Ltd (AGL):企業の財務・戦略的SWOT分析
    AGL Energy Ltd (AGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ARCA biopharma Inc (ABIO):企業の財務・戦略的SWOT分析
    Summary ARCA Biopharma Inc (ARCA), formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company’s product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique beta-blocker that is being developed for the treatment …
  • Pharco Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Pharco Pharmaceuticals Inc (Pharco Pharmaceuticals), a subsidiary of Pharco Corp, is a manufacturer of branded and generic pharmaceutical products. The company offers products such as alambupine, alfatral, amlodipine, amrase, amrizole, bisadyl, bromhexine, carbolase, ciprofloxacin, dexametha …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆